Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol

Scandinavian Journal of Urology

Volumn 47, Issue 2, 2013, Pages 108-112

  Liedberg, Fredrik ^a   Bendahl, Pär Ola ^a   Davidsson, Thomas ^b   Gudjonsson, Sigurdur ^a   Holmer, Magnus ^a   Månsson, Wiking ^a   Wallengren, Nils Olof ^a  

^a LUND UNIVERSITY   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bladder cancer; MRI; Radical cystectomy; Staging

Indexed keywords

ADVANCED CANCER; ARTICLE; BLADDER CANCER; BLADDER CAPACITY; CANCER INVASION; CANCER STAGING; CYSTECTOMY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE PERIOD; REPRODUCIBILITY OF RESULTS; URINARY BLADDER NEOPLASMS;

EID: 84875457086     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/00365599.2012.721394     Document Type: Article

References (13)

1. Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, et al. Treatment of muscleinvasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-18.
2. Madersbacher S, HochreiterW, Burkhard F, Thalmann GN, Danuser H, Markwalder R, et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;21:690-6.
3. Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol 2011;29:2171-7.
4. Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 2012;62:523-33.
5. Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, et al. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int 2011; 107:898-904.
6. Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y. Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 2008;81:399-402.
7. Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 1996;167:1503-7.
8. Sobin LH GM, Wittekind C. editors. UICC International Union Against Cancer: TNM classification of malignant tumours. 7th ed. Hoboken, NJ: Wiley-Blackwell; 2009.
9. Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005;184: 121-7.
10. El-Assmy A, Abou-El-Ghar ME, Mosbah A, El-Nahas AR, Refaie HF, Hekal IA, et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 2009;19:1575-81.
11. Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, et al. Urinary bladder cancer: diffusion-weighted MR imaging - accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009;251:112-21.
12. Watanabe H, Kanematsu M, Kondo H, Goshima S, Tsuge Y, Onozuka M, et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? AJR Am J Roentgenol 2009; 192:1361-6.
13. Froehlich JM, TriantafyllouM, Fleischmann A, Vermathen P, Thalmann GN, Thoeny HC. Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes? Contrast Media Mol Imaging 2012;7:346-55.